Search

Displaying results 8411 - 8420 of 10000 in total
  1. Drug

    Henatinib

    go.drugbank.com/drugs/DB13019
    Investigational

    Henatinib has been used in trials studying the treatment of Advanced Solid Cancer.

    Categories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds, 2-Ring
  2. Drug

    IPI-493

    go.drugbank.com/drugs/DB13023
    Investigational

    IPI-493 has been used in trials studying the treatment of Advanced Malignancies.

  3. Drug

    Tirilazad

    go.drugbank.com/drugs/DB13050
    Investigational

    Tirilazad has been used in trials studying the treatment of Spinal Cord Injury.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
  4. Drug

    CEP-37440

    go.drugbank.com/drugs/DB13060
    Investigational

    CEP-37440 has been used in trials studying the treatment of Solid Tumors.

  5. Drug

    LY-2811376

    go.drugbank.com/drugs/DB13065
    Investigational

    LY2811376 has been used in trials studying the basic science of Alzheimer's Disease.

    Categories: Heterocyclic Compounds, 1-Ring
  6. Drug

    AZD-0424

    go.drugbank.com/drugs/DB13088
    Investigational

    AZD0424 has been used in trials studying the treatment of Advanced Solid Tumours.

    Categories: Heterocyclic Compounds, 2-Ring
  7. Drug

    TAK-593

    go.drugbank.com/drugs/DB13093
    Investigational

    TAK-593 has been used in trials studying the treatment of Solid Tumors.

    Categories: Heterocyclic Compounds, 1-Ring
  8. Drug

    Suratadenoturev

    go.drugbank.com/drugs/DB18672
    Investigational

    Suratadenoturev is a gene-modified oncolytic adenovirus expressing the telomerase reverse transcriptase gene.

    Synonyms: A replication-competent adenovirus type 5 in which the E1A and E1B genes are under the control of a human telomerase reverse transcriptase (hTERT) and IRES, respectively., A recombinant replication-competent adenovirus type 5 (Ad-5) in which the E1 gene, including its normal transcriptional regulatory element, has been deleted and replaced by an expression cassette containing
  9. Drug

    Plasmin (Human)

    go.drugbank.com/drugs/DB22676
    Investigational

    The enzyme plasmin causes clot lysis by cleaving fibrin, a clot component.[L53453]

  10. Drug

    Ozagrel

    go.drugbank.com/drugs/DB12017
    Investigational

    Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.

    Categories: Thromboxane-A Synthase, antagonists & inhibitors